Long-term real-world efficacy of inclisiran at 15 months: new results from the INCLIVEN multicenter registry. // Atherosclerosis Plus. – URL: https://www.sciencedirect.com/science/article/pii/S2667089526000799?dgcid=rss_sd_all
Long-term real-world efficacy of inclisiran at 15 months: new results from the INCLIVEN multicenter registry. Atherosclerosis Plus. https://www.sciencedirect.com/science/article/pii/S2667089526000799?dgcid=rss_sd_all
“Long-term real-world efficacy of inclisiran at 15 months: new results from the INCLIVEN multicenter registry.” Atherosclerosis Plus.
@article{article36990,
title = {Long-term real-world efficacy of inclisiran at 15 months: new results from the INCLIVEN multicenter registry},
journal = {Atherosclerosis Plus},
url = {https://www.sciencedirect.com/science/article/pii/S2667089526000799?dgcid=rss_sd_all}
}
Abstract Background Macrophage polarisation plays a crucial role in sepsis‐associated inflammatory responses; however, the underlying molecular regulatory mechanisms remain to be further explored. Aim This study aimed to explore the...